Walleye Capital
BNTX icon

Walleye Capital’s BioNTech BNTX Stock Holding History

Walleye Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91M Buy
31,313
+22,247
+245% +$2.09M 0.01% 1206
2026
Q1 		$806K Sell
9,066
-8,253
-48% -$848K ﹤0.01% 2274
2025
Q4 		$1.65M Buy
17,319
+15,794
+1,036% +$1.59M 0.01% 2024
2025
Q3 		$150K Buy
1,525
+1,483
+3,531% +$159K ﹤0.01% 3490
2025
Q2 		$4.47K Sell
42
-2,914
-99% -$294K ﹤0.01% 4361
2025
Q1 		$269K Sell
2,956
-6,065
-67% -$679K ﹤0.01% 3028
2024
Q4 		$1.03M Sell
9,021
-6,396
-41% -$730K ﹤0.01% 2368
2024
Q3 		$1.83M Sell
15,417
-70,849
-82% -$6.51M ﹤0.01% 2050
2024
Q2 		$6.93M Buy
86,266
+47,460
+122% +$4.34M 0.01% 1030
2024
Q1 		$3.58M Buy
+38,806
New +$3.72M 0.01% 1558
2023
Q4 		– Sell
-35,147
Closed -$3.54M – 4954
2023
Q3 		$3.82M Buy
+35,147
New +$3.89M 0.01% 1236

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Walleye Capital's BNTX Position: Q2 2026 in Review

Walleye Capital increased its BioNTech (BNTX) stake by 245% in Q2 2026, buying an estimated $2.09M and bringing the position to 31,313 shares worth $2.91M. The position accounts for 0.01% of the portfolio, ranked #1206.

Walleye Capital first reported a position in BNTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.93M in Q2 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Walleye Capital held 31,313 shares of BioNTech worth $2.91M as of Q2 2026.
  • Walleye Capital bought 22,247 BioNTech shares in Q2 2026, an estimated $2.09M.
  • BioNTech made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1206 holding.
  • Walleye Capital first reported a position in BioNTech in Q3 2023 and has held it in 11 quarters since.
  • Walleye Capital's BioNTech position peaked at $6.93M in Q2 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.